161 related articles for article (PubMed ID: 18262058)
1. A novel mutation of the SMARCB1 gene in a case of extrarenal malignant rhabdoid tumor.
Koitabashi M; Kanazawa T; Tamura K; Tsukada S; Suzuki M; Morikawa A; Ogawa C; Hirado J
Cancer Genet Cytogenet; 2008 Feb; 181(1):67-8. PubMed ID: 18262058
[No Abstract] [Full Text] [Related]
2. SMARCB1/INI1 alterations and hepatoblastoma: another extrarenal rhabdoid tumor revealed?
Russo P; Biegel JA
Pediatr Blood Cancer; 2009 Mar; 52(3):312-3. PubMed ID: 19072985
[No Abstract] [Full Text] [Related]
3. Congenital Disseminated Extrarenal Malignant Rhabdoid Tumor.
Boudjemaa S; Petit A; Dainese L; Bourdeaut F; Lipsett J; Coulomb A
Pediatr Dev Pathol; 2015; 18(5):401-4. PubMed ID: 25751458
[TBL] [Abstract][Full Text] [Related]
4. Prenatal presentation of a metastasizing rhabdoid tumor with homozygous deletion of the SMARCB1 gene.
Negahban S; Nagel I; Soleimanpour H; Aledavood A; Bagheri N; Paydar M; Daneshbod K; Hasselblatt M; Gesk S; Siebert R; Daneshbod Y
J Clin Oncol; 2010 Nov; 28(33):e688-91. PubMed ID: 20805448
[No Abstract] [Full Text] [Related]
5. Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome.
Frühwald MC; Hasselblatt M; Wirth S; Köhler G; Schneppenheim R; Subero JI; Siebert R; Kordes U; Jürgens H; Vormoor J
Pediatr Blood Cancer; 2006 Sep; 47(3):273-8. PubMed ID: 16206192
[TBL] [Abstract][Full Text] [Related]
6. Pathology and diagnosis of SMARCB1-deficient tumors.
Margol AS; Judkins AR
Cancer Genet; 2014 Sep; 207(9):358-64. PubMed ID: 25246033
[TBL] [Abstract][Full Text] [Related]
7. SMARCB1/INI1 missense mutation in mucinous carcinoma with rhabdoid features.
Cho YM; Choi J; Lee OJ; Lee HI; Han DJ; Ro JY
Pathol Int; 2006 Nov; 56(11):702-6. PubMed ID: 17040295
[TBL] [Abstract][Full Text] [Related]
8. Introduction from the editor.
Biegel J
Cancer Genet; 2014 Sep; 207(9):345. PubMed ID: 25434579
[No Abstract] [Full Text] [Related]
9. Congenital extrarenal malignant rhabdoid tumor in an infant with distal 22q11.2 deletion syndrome: the importance of SMARCB1.
Chakrapani AL; White CR; Korcheva V; White K; Lofgren S; Zonana J; Moore S; Krol A; Mansoor A
Am J Dermatopathol; 2012 Aug; 34(6):e77-80. PubMed ID: 22814326
[TBL] [Abstract][Full Text] [Related]
10. Malignant rhabdoid tumors: a familial condition?
Anderson J
Pediatr Blood Cancer; 2011 Jan; 56(1):1-2. PubMed ID: 21108435
[No Abstract] [Full Text] [Related]
11. Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?
Renard C; Pissaloux D; Decouvelaere AV; Bourdeaut F; Ranchère D
Cancer Genet; 2014 Sep; 207(9):384-9. PubMed ID: 25053104
[TBL] [Abstract][Full Text] [Related]
12. Rhabdoid tumor predisposition syndrome caused by SMARCB1 constitutional deletion: prenatal detection of new case of recurrence in siblings due to gonadal mosaicism.
Gigante L; Paganini I; Frontali M; Ciabattoni S; Sangiuolo FC; Papi L
Fam Cancer; 2016 Jan; 15(1):123-6. PubMed ID: 26342593
[TBL] [Abstract][Full Text] [Related]
13. SMARCB1 deletion by a complex three-way chromosomal translocation in an extrarenal malignant rhabdoid tumor.
Bahrami A; Lee S; Caradine KD; Raimondi SC; Folpe AL
Cancer Genet; 2014 Sep; 207(9):437-40. PubMed ID: 25312828
[TBL] [Abstract][Full Text] [Related]
14. SMARCB1 gene with a 27-base pair (bp) deletion is not a mutation.
Sano K; Matsuda K; Yoichi K
Cancer Genet Cytogenet; 2010 May; 199(1):65. PubMed ID: 20417873
[No Abstract] [Full Text] [Related]
15. Re: Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor: Direct evidence of mutational inactivation of SMARCB1/INI1 in epithelioid sarcoma.
Flucke U; Slootweg PJ; Mentzel T; Pauwels P; Hulsebos TJ
Hum Pathol; 2009 Sep; 40(9):1361-2; author reply 1362-4. PubMed ID: 19683621
[No Abstract] [Full Text] [Related]
16. Genetic causes of familial risk in rhabdoid tumors.
Roberts CW
Pediatr Blood Cancer; 2006 Sep; 47(3):235-7. PubMed ID: 16304667
[No Abstract] [Full Text] [Related]
17. Conventional chondrosarcoma in a survivor of rhabdoid tumor: enlarging the spectrum of tumors associated with SMARCB1 germline mutations.
Forest F; David A; Arrufat S; Pierron G; Ranchere-Vince D; Stephan JL; Clemenson A; Delattre O; Bourdeaut F
Am J Surg Pathol; 2012 Dec; 36(12):1892-6. PubMed ID: 23154773
[TBL] [Abstract][Full Text] [Related]
18. Premature termination of SMARCB1 translation may be followed by reinitiation in schwannomatosis-associated schwannomas, but results in absence of SMARCB1 expression in rhabdoid tumors.
Hulsebos TJ; Kenter S; Verhagen WI; Baas F; Flucke U; Wesseling P
Acta Neuropathol; 2014 Sep; 128(3):439-48. PubMed ID: 24740647
[TBL] [Abstract][Full Text] [Related]
19. Clinical and molecular features in patients with atypical teratoid rhabdoid tumor or malignant rhabdoid tumor.
Kordes U; Gesk S; Frühwald MC; Graf N; Leuschner I; Hasselblatt M; Jeibmann A; Oyen F; Peters O; Pietsch T; Siebert R; Schneppenheim R
Genes Chromosomes Cancer; 2010 Feb; 49(2):176-81. PubMed ID: 19902524
[TBL] [Abstract][Full Text] [Related]
20. Clinical and genetic features of rhabdoid tumors of the heart registered with the European Rhabdoid Registry (EU-RHAB).
Bartelheim K; Sumerauer D; Behrends U; Kodetova D; Kucera F; Leuschner I; Neumayer P; Oyen F; Rübe C; Siebert R; Schneppenheim R; Seeringer A; Vasovcak P; Frühwald MC
Cancer Genet; 2014 Sep; 207(9):379-83. PubMed ID: 24972932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
